CSOP Hang Seng Biotech ETF (03174.HK) Rose 1.88%, with the Latest Price at HKD 3.570
Newtimespace News： As of 10:03 on May 7, the CSOP Hang Seng Biotech ETF (03174.HK) rose 1.88%, with the latest price at HKD 3.570, assets under management of approximately HKD 890 million.
Newtimespace News： As of 10:03 on May 7, the CSOP Hang Seng Biotech ETF (03174.HK) rose 1.88%, with the latest price at HKD 3.570, a high of HKD 3.596, a low of HKD 3.506, an average price of HKD 3.579, assets under management of approximately HKD 890 million, a latest net asset value of HKD 3.505, and a discount of 0.03%.
The CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong, reflecting the overall performance of Hong Kong's biotech sector.
Tags：
- Shaanxi Micot Pharmaceutical Technology Co., Ltd (02335.HK): Phase II Clinical Study of Dual-Function Antithrombotic Candidate MT1002 for Anticoagulation in Haemodialysis Completes First Patient Enrolment
- NEW CENTURY GP(00234.HK): Indirect Non-wholly-owned Subsidiary Grants HK$8.7 Million Mortgage Loan to Wong Kwok Keung and Jiayuan Holdings at 12% Per Annum
- TAT HONG EQUIP(02153.HK): 10th Digital Securities Commercial Paper Issuance; Annual Interest Rate 4.40%, Planned Raising of SGD30 Million–35 Million
- BE FRIENDS HLDG(01450.HK): Q2 2026 GMV Reaches Approximately RMB3.36 Billion; H1 Cumulative GMV Hits RMB6.53 Billion
- DONGJIANG ENV(00895.HK): Subsidiary Daxiang Logistics Wins Zhongnan Steel Road Transportation Tender Worth Approximately RMB18.49 Million
